UA

Usha Aggarwal

Active Director Director DIN 01377635
DIN 01377635 First appointment May 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2002
Shareholding value •••• Premium profile

About Usha Aggarwal

Data last updated:

Usha Aggarwal is a Director at Native Drugs Private Limited (since 2002). The company operates in Pharma. Native Drugs Private Limited reported revenue of ₹1.49 Cr (FY 2025).

DIN 01377635
Primary Designation Director
Industry Pharma
First Appointment 24 May 2002
Oldest Company Age 36 yrs
Largest company Native Drugs Private Limited · ₹1.49 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Native Drugs Private Limited U74899PB1990PTC047094
Director24 May 20021990₹1.49 Cr (FY 2025)Active

Board colleagues of Usha Aggarwal

NameDINCompanyDesignation
Ashok Kumar Aggarwal01377652Native Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Native Drugs Private Limited
Premium access

Shareholding and investment profile for Usha Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usha Aggarwal

Usha Aggarwal currently holds 1 directorship: Native Drugs Private Limited (Director, since 24 May 2002, revenue ₹1.49 Cr (FY 2025)).

Usha Aggarwal was first appointed on 24 May 2002 as Director at Native Drugs Private Limited.

The current boards of Usha Aggarwal's companies include Ashok Kumar Aggarwal (Native Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available